ARUP's Laboratory Test Directory

Lymphocyte Transplantation Profile : 0095798
[ image for: Time Sensitive]
Time Sensitive
  


Mnemonic: LYMPHPRO

Methodology: Quantitative Flow Cytometry
Performed: Sun-Sat
Reported: Within 24 hours
Specimen Required: Patient Prep: Draw specimen before administering immunosuppressive medications.

Collect: Green (sodium or lithium heparin), lavender (EDTA) or pink (K2EDTA).

Specimen Preparation: Transport 5 mL whole blood. (Min: 1 mL)

Storage/Transport Temperature: CRITICAL ROOM TEMPERATURE.

Remarks: Specimens must be analyzed within 48 hours of collection. Some medications may affect immunophenotyping results and should be listed on the patient test request form.
THIS TEST IS FOR TRANSPLANT PATIENTS ONLY. WBC and lymphocyte percent results with the same draw date and time as the Lymphocyte Transplantation Profile specimen must be provided by client.
New York State Clients: EDTA specimens must be analyzed within 30 hours of collection. Heparin specimens must be analyzed within 48 hours of collection.

Unacceptable Conditions: Clotted, hemolyzed, frozen, or refrigerated specimens. Specimens older than 48 hours.
New York State Clients: Clotted, hemolyzed, frozen, or refrigerated specimens. EDTA specimens older than 30 hours and heparin specimens older than 48 hours.

Stability (collection to initiation of testing): Ambient: 48 hours; Refrigerated: Unacceptable; Frozen: Unacceptable
New York State Clients: Ambient: 30 hours in EDTA, 48 hours in heparin; Refrigerated: Unacceptable; Frozen: Unacceptable
Reference Interval:
Reports include age appropriate reference intervals and interpretation.
Components Reference Interval
%CD2 By report
Absolute CD2 By report
%CD3 By report
Abs CD3 By report
%CD4 By report
%CD8 By report
CD4: CD8 ratio By report
%CD19 By report

Interpretive Data: In this test, the percent CD3 cells are those cells that are positive for both CD3 and the alpha-beta chain of the T-cell receptor and are presumed immunologically competent.

Refer to Statement A under Testing Information at http://www.aruplab.com.
Note: THIS TEST IS FOR TRANSPLANT PATIENTS ONLY.  Immunosuppressive therapy with anti-lymphocyte drugs, such as OKT3 or ATG (anti-thymocyte globulin), can be monitored with this test.  For immunocompromised patients, order Lymphocyte Subset Panel 5 - Total Lymphocyte Enumeration (0095892).
CPT Code(s): 86356 CD2; 86356 CD3; 86356 CD4; 86356 CD8; 86356 CD19; 86356 ALPHA/BETA
Cross References: Post Transplant CD2 and CD3 Monitoring, Percent and Absolute (Lymphocyte Transplantation Profile)
 
 

 

 

 
All ARUP Sites:        www.aruplab.com     ·     www.arupconsult.com     ·     www.arup.utah.edu     ·     www.childx.org     ·     www.utahblood.org